Kenz Tablet contains Ketoconazole 200 mg, an antifungal agent belonging to the imidazole class, indicated for the treatment of various fungal infections. Ketoconazole exerts its effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Kenz Tablet is primarily prescribed for systemic and superficial mycoses, including candidiasis, dermatophytosis, and pityriasis versicolor. It is also effective against infections caused by susceptible strains of fungi such as Candida albicans, Trichophyton species, and Malassezia furfur. The recommended dosage and duration of therapy depend on the type and severity of the infection, and treatment should be guided by a healthcare professional. Kenz Tablet should be taken orally with water, preferably after meals to minimize gastrointestinal discomfort. Caution is advised in patients with hepatic impairment, as Ketoconazole has been associated with hepatotoxicity; liver function tests should be monitored during prolonged therapy. Contraindications include hypersensitivity to Ketoconazole or other azole antifungals. Potential side effects include gastrointestinal disturbances, headache, dizziness, and, rarely, serious hepatic adverse effects. Patients should inform their physician of any concomitant medications due to possible drug interactions. Kenz Tablet offers an effective therapeutic option for managing fungal infections when used appropriately under medical supervision.